Mirum Pharmaceuticals, Inc. - common stock (NQ:MIRM)
All News about Mirum Pharmaceuticals, Inc. - common stock
Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation
April 14, 2025
Via Business Wire
LIVMARLI Now Approved in Japan for ALGS and PFIC
March 27, 2025
Via Business Wire